Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer
申请人:Connell D. Richard
公开号:US20050101618A1
公开(公告)日:2005-05-12
This invention relates to a method of treatment of cancer with a combination of an erbB2 ligand and an antibody, in mammals. More particularly, this invention relates to a method of treating cancer by administering an erbB2 ligand in combination with an erbB antibody. This invention also relates to a kit useful in the treatment of abnormal cell growth in mammals, especially humans.
本发明涉及一种在哺乳动物中使用erbB2配体和抗体的组合治疗癌症的方法。更具体地,本发明涉及通过联合给予erbB2配体和erbB抗体来治疗癌症的方法。本发明还涉及一种在哺乳动物,特别是人类中治疗异常细胞生长的有用工具包。